Seoul Cefixime Capsule (Cefixime Hydrate)

Adult dose

Adults: Administer 50～100 mg (potency) of cefixime orally twice daily. In severe cases or when the response is inadequate, administer 200 mg (potency) twice daily. Adjust the dose as appropriate according to age and symptoms.

Child dose

Children weighing 30 kg or more: Administer 50～100 mg (potency) of cefixime orally twice daily. In severe cases or when the response is inadequate, administer 200 mg (potency) twice daily.

This medication should not be administered to certain patients. Patients who have had severe allergic reactions or shock due to this medication in the past, those allergic to cephalosporin antibiotics, and those with genetic issues that affect lactose digestion should not use this medication. Additionally, patients with a history of allergic reactions, severely impaired kidney function, those receiving parenteral nutrition, and elderly individuals should use this medication with caution. It is especially important to be cautious if the patient is allergic to the color additive Yellow No. 5. When using this medication, rare but severe allergic reactions, breathing difficulties, skin rashes, severe diarrhea, interstitial pneumonia, blood abnormalities, seizures, liver dysfunction, and kidney function impairment may occur, hence symptoms should be closely monitored. If abnormal symptoms arise, administration should be stopped immediately and appropriate treatment should be sought. This medication should only be used for a minimal duration after confirming susceptibility to prevent the occurrence of resistant bacteria, and dosage adjustments may be necessary for patients with impaired kidney function. This medication can interact with specific drugs such as warfarin, increasing the risk of side effects; therefore, patients should inform healthcare professionals of any other medications they are taking. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication, and it is advisable to avoid breastfeeding during the treatment period. Safety for neonates or infants under 6 months has not been established, so caution is required when using this medication. For the elderly, the likelihood of side effects may increase due to decreased bodily functions, thus dosage and administration intervals should be adjusted and closely monitored. Finally, this medication may affect test results, so it is essential to inform healthcare professionals that this medication is being taken during testing.

Shock, discomfort, oral dysesthesia, wheezing, dizziness, stool abnormalities, tinnitus, sweating, anaphylactic symptoms, breathlessness, generalized flushing, edema, urticaria, rash, erythema, itching, fever, erythema multiforme, serum sickness-like reaction, abdominal pain, leukocytosis, severe diarrhea accompanied by mucus and blood, pseudomembranous colitis, vomiting, diarrhea, upper abdominal discomfort, heartburn, appetite loss, nausea, abdominal distension, constipation, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, eosinophilic pulmonary infiltration, granulocytopenia, hemolytic anemia, thrombocytopenia, agranulocytosis, prolonged prothrombin time, seizures, toxic epidermal necrolysis, Stevens-Johnson syndrome, liver dysfunction, jaundice, acute renal failure, stomatitis, candidiasis, symptoms of vitamin K deficiency, hypoprothrombinemia, bleeding tendency, symptoms of vitamin B deficiency, glossitis, neuritis, headache, anxiety, genital itching, vaginitis

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the efficacy of the medication for an extended period.

Appearance

A hard capsule with light orange upper and lower parts containing a white to light yellow crystalline powder

Package unit

30 capsules/bottle, 100 capsules/bottle